T1	Participants 127 183	patients with mixed dyslipidaemia and metabolic syndrome
T2	Participants 585 627	patients with mixed dyslipidaemia and MetS
T3	Participants 662 744	patients with low-density lipoprotein cholesterol (LDL-C) > 160 and TG > 200â€ƒmg/dl
T4	Participants 793 800	n = 30)
T5	Participants 875 882	n = 30)
T6	Participants 921 927	n = 30
T7	Participants 952 989	only patients with MetS were included